Objetivo
Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role in the drive towards personalised medicine remains uncertain.
Based on harmonised and standardised European population cohorts we have built significant research collaboration, expertise and infrastructure in the EU. We will apply highly innovative SME-driven technologies and perform large-scale biomarker determination to assess the predictive value of existing and emerging biomarkers.
Selection of emerging biomarkers will be based on integrated cutting-edge quantitative proteomic, transcriptomic, metabolomic, and miRNomic datasets established by private and public consortium members that will be disclosed to this consortium. Existing biomarkers will be selected based on non-redundancy and their association with cardiovascular risk and phenotypes. After SME-guided development of innovative assay systems biomarkers will be tested and validated in a stepwise fashion among European populations in primary and secondary prevention. In addition to their impact on risk prediction, their association with lifestyle determinants and cardiovascular phenotypes assessed by ultrasound and MRI technique will be evaluated.
We will establish a BiomarCaRE panel which leads to improved disease prediction among different European populations. International collaborations with world-class clinical trial investigators will add data on the interaction of the BiomarCaRE panel with risk-lowering medication and lifestyle changes. The outcome of SME-driven technology development and clinical validation will undergo a medical technology assessment. The determination of cost-effectiveness will guide further clinical evaluation. These studies will reveal new methods of improved cardiovascular risk estimation and will open the path towards personalised medicine.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2011-two-stage
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-FP - Small or medium-scale focused research projectCoordinador
20251 Hamburg
Alemania
Ver en el mapa
Participantes (29)
00271 Helsinki
Ver en el mapa
3511 GC UTRECHT
Ver en el mapa
3584 CX Utrecht
Ver en el mapa
85764 Neuherberg
Ver en el mapa
6020 Innsbruck
Ver en el mapa
23562 Lubeck
Ver en el mapa
6060 HALL IN TYROL
Ver en el mapa
30625 Hannover
Ver en el mapa
RG27 8DH HARTLEY WINTNEY HANTS
Ver en el mapa
La participación finalizó
1015 Lausanne
Ver en el mapa
EC1V 4PY LONDON
Ver en el mapa
55131 Mainz
Ver en el mapa
9019 Tromso
Ver en el mapa
20123 Milano
Ver en el mapa
17489 Greifswald
Ver en el mapa
WC1E 6BT London
Ver en el mapa
BT7 1NN Belfast
Ver en el mapa
59019 Lille
Ver en el mapa
08025 Barcelona
Ver en el mapa
901 87 Umea
Ver en el mapa
51005 Tartu
Ver en el mapa
3400 Hillerod
Ver en el mapa
21100 Varese
Ver en el mapa
DD1 4HN Dundee
Ver en el mapa
4031 Basel
Ver en el mapa
89081 Ulm
Ver en el mapa
La participación finalizó
L8S 4L8 HAMILTON
Ver en el mapa
2006 Sydney
Ver en el mapa
86077 Pozzilli Is
Ver en el mapa